샘플 요청 목록

 카트 문의
시장보고서
상품코드
1737370

세계의 자간전증 진단 시장

Preeclampsia Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 376 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

자간전증 진단 세계 시장은 2030년까지 35억 달러에 달할 전망

2024년에 20억 달러로 추정되는 자간전증 진단 세계 시장은 2024년부터 2030년까지 CAGR 9.6%로 성장하여 2030년에는 35억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 혈액 검사는 CAGR 11.0%를 기록하며 분석 기간 종료까지 22억 달러에 달할 것으로 예측됩니다. 소변 분석 분야의 성장률은 분석 기간 동안 CAGR 7.3%로 추정됩니다.

미국 시장은 5억 5,610만 달러로 추정, 중국은 CAGR 13.4%로 성장 예측

미국의 자간전증 진단 시장은 2024년에 5억 5,610만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 13.4%로 추정되며, 2030년에는 7억 2,740만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 6.7%와 8.6%로 예측됩니다. 유럽에서는 독일이 CAGR 7.6%로 성장할 것으로 예측됩니다.

세계 자간전증 진단 시장 - 주요 동향 및 촉진요인 정리

자간전증 조기 발견이 임상적으로 우선시되는 이유는 무엇인가?

고혈압과 잠재적인 장기 손상을 특징으로 하는 임신 합병증인 자간전증은 전 세계적으로 산모와 신생아 사망률의 주요 원인이 되고 있습니다. 자간전증을 치료하지 않으면 생명을 위협하는 자간증으로 발전하거나 조산으로 이어질 수 있기 때문에 조기 발견이 중요합니다. 헬스케어 시스템이 예방적 산전 관리에 중점을 두고 있는 가운데 자간전증 진단 솔루션이 주목받고 있습니다. 최근의 기술 혁신에는 sFlt-1/PlGF 비율과 같은 바이오마커를 기반으로 한 혈액 검사가 포함되며, 이를 통해 조기에 신뢰할 수 있는 위험 계층화를 가능하게 합니다. 또한, 휴대용 분석기 및 디지털 모니터링과 통합된 현장 검사도 등장하여 도시 병원과 원격진료소 모두에서 산모 관리를 지원하고 있습니다. 이러한 진단 방법은 적시에 개입할 수 있게함으로써 임신 결과를 개선하고, 집중 치료 서비스의 부담을 줄임으로써 산모 관리의 형태를 바꾸고 있습니다.

진단 역량을 추진하는 주요 이해관계자는 누구인가?

이 진화하는 시장의 이해관계자에는 의료기기 제조업체, 산부인과 의료 서비스 제공자, 학술 연구자, 공중 보건 기관이 포함됩니다. 진단 회사들은 임상 증상이 나타나기 훨씬 전에 혈청 및 혈장 내 바이오마커를 검출하기 위해 더 높은 민감도와 특이성을 가진 분석법을 개발하고 있습니다. 병원과 산전 진단 클리닉에서는 고위험 임신을 조기에 선별하기 위해 이러한 검사를 표준 치료 경로에 통합하고 있습니다. 한편, 연구기관에서는 차세대 진단에 사용될 수 있는 유전체 및 단백질체학 시그니처를 연구하고 있으며, 세계보건기구(WHO)와 유니세프(UNICEF)와 같은 세계보건기구는 특히 자간전증 관련 사망률이 여전히 높은 저소득 국가에서 산모 검진 프로그램을 추진하고 있습니다. 공공 기관과 민간 기업과의 협력을 통해 보조금 프로그램과 모바일 헬스 이니셔티브를 통해 저렴한 진단약에 대한 접근성이 확대되고 있습니다.

세계 시장은 지역별로 어떻게 변화하고 있는가?

자간전증 진단의 지역별 도입 현황은 의료 인프라, 산모 사망률, 규제 준비 정도에 따라 차이가 있습니다. 북미와 서유럽은 이미 확립된 선별검사 프로토콜과 고급 검사를 지원하는 광범위한 보험 적용으로 인해 주요 도입 국가로 꼽힙니다. 아시아태평양에서는 중국, 일본, 인도의 도시 지역이 인식이 높아지고 산모 관리 인프라가 확충됨에 따라 바이오마커 분석이 빠르게 도입되고 있습니다. 사하라 사막 이남의 아프리카와 라틴아메리카의 일부 지역에서는 접근성과 경제성 문제에 직면해 있지만, 이동 진료소와 원격의료 플랫폼이 그 격차를 일부 해소하고 있습니다. 세계 이니셔티브는 선진국 시장의 기부금과 기술 이전을 통해 이러한 의료 서비스가 부족한 지역에 현장 진단 도구를 광범위하게 보급하는 것을 촉진하고 있습니다. 이러한 지역적 차이는 임산부 건강 우선순위를 둘러싼 다양한 성숙도와 시급성을 반영합니다.

진단 솔루션의 확장을 촉진하는 요인은 무엇인가?

자간전증 진단 시장의 성장은 임상 수요, 의료 정책, 기술 발전에 기반한 여러 요인에 의해 주도되고 있습니다. 임산부의 건강 위험과 조기 개입의 이점에 대한 인식이 높아지면서 산부인과 의사들이 산전 진료의 일환으로 바이오마커 기반 검사를 채택하고 있습니다. 면역분석, 바이오센서, 미세유체공학의 발달로 신속하고 정확하며 확장 가능한 진단 플랫폼의 개발이 가능해졌습니다. 산모의 고령화, 비만, 고혈압 기왕력 등의 요인으로 인한 고위험 임신의 증가로 인해 신뢰할 수 있는 선별검사의 필요성이 증가하고 있습니다. 선진국과 신흥국을 막론하고 지원적인 보건 정책과 산전 관리에 대한 인센티브가 시장 개척을 촉진하고 있습니다. 또한, 진단 개발 기업과 헬스케어 NGO와의 파트너십을 통해 자원이 부족한 환경에서 비용 효율적으로 검사 솔루션을 배포할 수 있어 전 세계적으로 확산과 영향력을 높일 수 있습니다.

부문

검사 유형(혈액 검사, 소변 분석, 기타 검사 유형), 제품 유형(장비, 소모품), 최종사용자(병원, 전문 클리닉, 진단 센터, 기타 최종사용자)

조사 대상 기업 사례(총 43개사)

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Diabetomics, Inc.
  • DRG Instruments GmbH
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Metabolomic Diagnostics Ltd.
  • Natera, Inc.
  • PerkinElmer Inc.
  • QuidelOrtho Corporation
  • Sera Prognostics, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

각국의 최종 리셋이 발표되는 7월에도 고객님들께 무료 업데이트를 제공할 예정입니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트를 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.06.12

Global Preeclampsia Diagnostics Market to Reach US$3.5 Billion by 2030

The global market for Preeclampsia Diagnostics estimated at US$2.0 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Blood Tests, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Urine Analysis segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$556.1 Million While China is Forecast to Grow at 13.4% CAGR

The Preeclampsia Diagnostics market in the U.S. is estimated at US$556.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$727.4 Million by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global "Preeclampsia Diagnostics" Market - Key Trends & Drivers Summarized

Why Is Early Detection of Preeclampsia Gaining Clinical Priority?

Preeclampsia, a pregnancy complication marked by high blood pressure and potential organ damage, is a leading cause of maternal and neonatal morbidity worldwide. Early detection is critical, as untreated preeclampsia can escalate into life-threatening eclampsia or lead to premature births. As healthcare systems emphasize preventive prenatal care, diagnostic solutions for preeclampsia are receiving increased attention. Recent innovations include biomarker-based blood tests such as the sFlt-1/PlGF ratio, which enables early and reliable risk stratification. Point-of-care testing, integrated with portable analyzers and digital monitoring, is also emerging to support maternal care in both urban hospitals and remote clinics. These diagnostics are reshaping prenatal care by enabling timely intervention, thereby improving pregnancy outcomes and reducing the burden on intensive care services.

Who Are the Primary Stakeholders Advancing Diagnostic Capabilities?

Stakeholders in this evolving market include medical device manufacturers, obstetric care providers, academic researchers, and public health agencies. Diagnostic companies are developing assays with higher sensitivity and specificity to detect biomarkers in serum or plasma well before clinical symptoms appear. Hospitals and prenatal clinics are integrating these tests into standard care pathways to stratify high-risk pregnancies early on. Meanwhile, research institutions are exploring genomic and proteomic signatures for potential use in next-gen diagnostics. Global health agencies such as WHO and UNICEF are promoting maternal screening programs, particularly in low-income countries where preeclampsia-related mortality remains high. Collaborations between public entities and private players are expanding access to affordable diagnostics through subsidized programs and mobile health initiatives.

How Is the Global Market Adapting Across Regions?

Regional adoption of preeclampsia diagnostics varies based on healthcare infrastructure, maternal mortality rates, and regulatory readiness. North America and Western Europe are leading adopters, with established screening protocols and widespread insurance coverage supporting advanced testing. In Asia-Pacific, urban areas in China, Japan, and India are seeing rapid implementation of biomarker assays, driven by rising awareness and the expansion of maternal care infrastructure. Sub-Saharan Africa and parts of Latin America face challenges with access and affordability, but mobile clinics and telehealth platforms are bridging some gaps. Global initiatives are encouraging broader deployment of point-of-care diagnostic tools in these underserved regions, supported by donations and technology transfer from developed markets. These regional variations reflect the diverse maturity levels and urgency surrounding maternal health priorities.

What Is Driving the Expansion of Diagnostic Solutions?

The growth in the preeclampsia diagnostics market is driven by several factors rooted in clinical demand, healthcare policy, and technological evolution. Rising awareness of maternal health risks and early intervention benefits is pushing obstetricians and gynecologists to adopt biomarker-based tests as part of routine prenatal care. Advances in immunoassays, biosensors, and microfluidics have enabled the development of fast, accurate, and scalable diagnostic platforms. The increasing prevalence of high-risk pregnancies-due to factors such as older maternal age, obesity, and pre-existing hypertension-is amplifying the need for reliable screening. Supportive health policies and prenatal care incentives in both developed and developing countries are facilitating wider market access. Furthermore, partnerships between diagnostic developers and healthcare NGOs are enabling cost-effective deployment of testing solutions in resource-limited settings, thereby enhancing global penetration and impact.

SCOPE OF STUDY:

The report analyzes the Preeclampsia Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Blood Tests, Urine Analysis, Other Test Types); Product Type (Instruments, Consumables); End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Diabetomics, Inc.
  • DRG Instruments GmbH
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Metabolomic Diagnostics Ltd.
  • Natera, Inc.
  • PerkinElmer Inc.
  • QuidelOrtho Corporation
  • Sera Prognostics, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Preeclampsia Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Maternal Mortality Awareness Throws Spotlight on Early Preeclampsia Diagnostics
    • Advancements in Biomarker-Based Testing Propel Accuracy in Risk Stratification
    • Government-Backed Maternal Health Programs Drive Diagnostic Testing Accessibility
    • Growing Prenatal Screening Adoption Expands Addressable Market for Preeclampsia Tests
    • Integration of AI and Predictive Models Enhances Diagnostic Decision Support Systems
    • First-Trimester Risk Screening Gains Traction for Early Prevention and Monitoring
    • Shift Toward Point-of-Care Diagnostics Strengthens Case for Portable Preeclampsia Test Kits
    • Increased Investment in Womens Health Innovation Spurs R&D in Novel Testing Methods
    • Healthcare Equity Initiatives Drive Focus on Underserved Populations in LMICs
    • Rising Use of Telehealth Platforms Expands Reach of Remote Diagnostic Consultations
    • Incorporation of Multi-Omics and Genetic Markers Enhances Predictive Testing Accuracy
    • Growing Awareness Among OB/GYNs and Midwives Accelerates Screening Rates
    • Private-Public Collaborations Support Development of Cost-Effective Diagnostic Tools
    • Postpartum Monitoring Programs Propel Demand for Repeat or Follow-Up Diagnostic Use
    • Clinical Guidelines and Protocol Updates Encourage Routine Screening in High-Risk Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preeclampsia Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preeclampsia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Blood Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Urine Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Urine Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Urine Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Preeclampsia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Preeclampsia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Preeclampsia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Preeclampsia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제